tradingkey.logo

Amgen Posts Q4 Total Rev $9.87 Bln VS IBES Estimate $9.47 Bln

ReutersFeb 3, 2026 11:35 PM

- Amgen Inc AMGN.O:

  • AMGEN OUTLOOK FY26 ADJUSTED EPS $21.60-$23.00 VERSUS IBES ESTIMATE $22.09

  • AMGEN Q4 ADJUSTED EPS $5.29 VERSUS IBES ESTIMATE $4.73

  • AMGEN OUTLOOK FY26 TOTAL REVENUE $37.0 BILLION-$38.4 BILLION VERSUS IBES ESTIMATE $37.08 BILLION

  • AMGEN Q4 TOTAL REVENUE $9.87 BILLION VERSUS IBES ESTIMATE $9.47 BILLION

  • AMGEN: PHASE 1 STUDY OF AMG 513 ENROLLING ADULTS LIVING WITH OBESITY

  • AMGEN: TO INITIATE PHASE 3 STUDIES OF MARITIDE IN PEOPLE LIVING WITH TYPE 2 DIABETES IN 2026

  • AMGEN OUTLOOK FY26 SHARE REPURCHASES NOT TO EXCEED $3 BILLION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI